KIYOSU, Japan–(BUSINESS WIRE)–Toyoda Gosei Co., Ltd. (TOKYO:7282) has invested in Genial Light Co., Ltd., a startup that develops testing equipment and other devices for medical institutions, with the aim of promoting product development in the healthcare field.
In recent years, Toyoda Gosei has focused increasingly on innovations that exploit its core technologies in order to achieve sustainable growth during a time of great upheaval in the automotive industry. The company is pioneering new businesses and developing products in the healthcare and other fields for which there is rising social demand. Examples include the development of deep UV LEDs for bacterial and viral disinfection and e-Rubber, a new material that is promising for use as a flexible sensor.
Since its foundation in 2006, Genial Light has worked together with medical device manufacturers and applied its optical technologies to develop small inspection devices for international markets. This includes devices that provide highly accurate measurements of biological information, such as pulse and blood components, and devices that measure blood in patients� urine and hemoglobin concentration while they are receiving dialysis.
Toyoda Gosei will integrate Genial Lights expertise in the medical and healthcare business in accelerating practical application of products that contribute to a healthier and safer society.
Outline of Genial Light
Company name | Genial Light Co., Ltd. |
Location | Taijuseimei Hamamatsu Building 8F, 145-1 Tokiwacho, Naka-ku, Hamamatsu, Shizuoka, Japan |
CEO | Ryo Shimokita |
Founded | November, 2006 |
Capital | 223 million yen (as of February 28, 2021) |
Contacts
Toyoda Gosei Co., Ltd.
Contact: Takatomo Abe
inquiry@mail.toyoda-gosei.co.jp
VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…
DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…
SINGAPORE - Media OutReach Newswire - 3 May 2024 - UPCX (UPC), a developer of…
DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights &…